SPI Pharma, Inc. and Inimmune, Corp. Partner to Develop and Commercialize Innovative Vaccine Adjuvant Systems
Published on 08/07/2025 at 18:00 | prnewswire.co.uk
View original content:https://www.prnewswire.co.uk/news-releases/spi-pharma-inc-and-inimmune-corp-partner-to-develop-and-commercialize-innovative-vaccine-adjuvant-systems-302198100.html
en | boerse | 68019849 |
